Clinical trial

Dose-finding Study With Lu AA24530 in Major Depressive Disorder

NCT00599911

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE2

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2016-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Lu AA24530DRUG

DuloxetineDRUG

PlaceboDRUG

Sponsors & collaborators

H. Lundbeck A/Slead sponsor

Mapped research locations

PragueCzechia4 ViennaAustria3 SeoulSouth Korea2 HelsinkiFinland2 Kuala LumpurMalaysia2 Saint PetersburgRussia1 MontpellierFrance1 StockholmSweden1 KyivUkraine1 BrnoCzechia1 KharkivUkraine1 RouenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00599911 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.